| Application Number | Application Type | Drug Name | Active Ingredients | Dosage Form/Route | Approval Date | Company |
|---|---|---|---|---|---|---|
| 211897 | ANDA | APREMILAST | APREMILAST | TABLET;ORAL | 2022-08-18 | TEVA PHARMS USA INC |
| 211878 | ANDA | APREMILAST | APREMILAST | TABLET;ORAL | 2019-06-24 | ANNORA |
| 211859 | ANDA | APREMILAST | APREMILAST | TABLET;ORAL | 2022-02-03 | ZYDUS PHARMS |
| 211819 | ANDA | APREMILAST | APREMILAST | TABLET;ORAL | 2021-02-17 | UNICHEM |
| 211782 | ANDA | APREMILAST | APREMILAST | TABLET;ORAL | 2021-06-30 | AMNEAL |
| 211774 | ANDA | APREMILAST | APREMILAST | TABLET;ORAL | 2023-04-07 | SHILPA |
| 211761 | ANDA | APREMILAST | APREMILAST | TABLET;ORAL | 2021-09-21 | ALKEM LABS LTD |
| 211756 | ANDA | APREMILAST | APREMILAST | TABLET;ORAL | 2019-11-15 | DR REDDYS |
| 211734 | ANDA | APREMILAST | APREMILAST | TABLET;ORAL | 2019-04-18 | MANKIND PHARMA |
| 211716 | ANDA | APREMILAST | APREMILAST | TABLET;ORAL | AUROBINDO PHARMA LTD | |
| 211674 | ANDA | APREMILAST | APREMILAST | TABLET;ORAL | 2020-12-29 | GLENMARK PHARMS LTD |
| 206088 | NDA | OTEZLA | APREMILAST | TABLET;ORAL | 2014-09-23 | CELGENE CORP |
| 205437 | NDA | OTEZLA | APREMILAST | TABLET;ORAL | 2014-03-21 | AMGEN INC |